2005
DOI: 10.1377/hlthaff.24.4.1039
|View full text |Cite
|
Sign up to set email alerts
|

Use And Costs Of Bariatric Surgery And Prescription Weight-Loss Medications

Abstract: The extent of use of bariatric surgery and weight-loss medications is unknown. Using the Nationwide Inpatient Sample, we estimate that the number of bariatric surgeries grew 400 percent between 1998 and 2002; such surgeries were performed on 0.6 percent of the 11.5 million adults clinically eligible in 2002. Hospital costs for bariatric surgery grew sixfold to $948 million in 2002. The inpatient death rate declined 64 percent. Among employers that covered weight-loss drugs in 2002, less than 2.4 percent of adu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
59
0
2

Year Published

2005
2005
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 107 publications
(61 citation statements)
references
References 13 publications
0
59
0
2
Order By: Relevance
“…A key limitation is that the majority of the study population is women, which is perhaps explained by the relative distribution of bariatric surgery in men versus women. 43 This study repurposed administrative data from Memorial Hermann's EPSI database. Since administrative data were used to identify ORADEs and relied on documentation of specific ICD-9-CM codes, the true incidence of ORADEs in this population may be greater than what was have the potential to improve the postsurgical experience for the patient and reduce costs for hospitals and may be more cost-efficient than interventions applied to the entire surgical population.…”
Section: Limitationsmentioning
confidence: 99%
“…A key limitation is that the majority of the study population is women, which is perhaps explained by the relative distribution of bariatric surgery in men versus women. 43 This study repurposed administrative data from Memorial Hermann's EPSI database. Since administrative data were used to identify ORADEs and relied on documentation of specific ICD-9-CM codes, the true incidence of ORADEs in this population may be greater than what was have the potential to improve the postsurgical experience for the patient and reduce costs for hospitals and may be more cost-efficient than interventions applied to the entire surgical population.…”
Section: Limitationsmentioning
confidence: 99%
“…[1][2][3] Unfortunately, the high cost (ranging from $18 000 to $25 000) 4,5 makes self-pay untenable for most bariatric patients, forcing them to rely on third party payment. 6 US insurance carriers generally offer coverage for these procedures to candidates meeting the NIH criteria, but often require participation in a 6-month, physician-supervised weight loss regimen.…”
Section: Introductionmentioning
confidence: 99%
“…In 2005, 180,000 bariatric procedures were performed, and in 2006, over 200,000 procedures are expected 8 . Factors contributing to such growth may include the prevalence of obesity, the increase in reports of surgical efficacy, the availability of less invasive procedures, and the media exposure of successful bariatric procedures 9 . Still, less than 1% of the 23 million morbidly obese patients in the United States undergo bariatric procedures.…”
Section: Introductionmentioning
confidence: 99%
“…Still, less than 1% of the 23 million morbidly obese patients in the United States undergo bariatric procedures. 9 One possible explanation for the disparity between potentially eligible patients and numbers of procedures performed is financial, i.e., patients may not be able to gain insurance coverage or have the ability to pay for a procedure out of pocket. Another potential reason is uncertainty regarding potential risks and benefits among both patients and referring physicians.…”
Section: Introductionmentioning
confidence: 99%